FDA Inspection 1270545 — Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd. on April 11, 2025 in Dongyang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 11, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dongyang (China)